Activ Surgical Announces FDA Clearance for ActivSight Intraoperative Imaging Module

Activ Surgical announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ActivSight Intraoperative Imaging Module for enhanced surgical visualization.

Metrex Surface Disinfectant Portfolio Secures EPA Approval

The U.S. Environmental Protection Agency (EPA) has approved all eight surface disinfectant products made by an infection prevention leader, Metrex, as effective against SARS-CoV-2, the novel coronavirus that causes COVID-19.

Olympus Supports Safety Actions Regarding Surgical Smoke

Olympus has announced its support of The Joint Commission’s recommended safety actions for managing the hazards of exposure to surgical smoke for health care staff in operating rooms.

Exofin Fusion Redesign Receives FDA Approval

Chemence Medical, a leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration’s (FDA) 510(k) approval of the company’s redesigned exofin fusion skin closure system.

New BioPledge Bleach And Alcohol-Free Daily Disinfectant Approved By EPA For Use Against COVID-19 Virus

BioPledge® Antimicrobial POWER

BioPledge LLC announced today the U. S. Environmental Protection Agency (EPA) approval of BioPledge® Antimicrobial POWER™ healthcare disinfectant for kill claims against SARS-CoV-2, the novel coronavirus that causes COVID-19, on hard non-porous surfaces. The new multi-purpose disinfectant and cleaner has been added to the EPA’s List N under EPA Reg No. 91691-1.

Now commercially available, the antimicrobial spray solution from Texas-based company, BioPledge, BioPledge Antimicrobial POWER has been approved for daily use, after being tested and proven effective to kill the COVID-19 virus.

Eliminating 99.9 percent of SARS-CoV-2 virus (associated with COVID-19) in three (3) minutes, “BioPledge Antimicrobial POWER provides a valuable everyday tool to maintain a clean environment,” said Alex Baranga, BioPledge President and Founder. “BioPledge is uniquely positioned to offer our healthcare disinfectant formula for broader use in automotive, commercial, healthcare, manufacturing, food service, education, mass transit and entertainment industries. Our mission is to provide peace of mind to help businesses get back to business, and the public back in public.”

The EPA authorization has been afforded to BioPledge only after extensive review of independent lab testing data. Specific performance criteria to evaluate efficacy of products must first be met. The independent lab research for BioPledge Antimicrobial POWER was conducted by an ISO 17025 accredited independent lab with over five decades of experience.

For more information on BioPledge Antimicrobial POWER™ and BioPledge® portfolio of products, visit



Submit a Comment

Your email address will not be published. Required fields are marked *